PER 2.50% 8.2¢ percheron therapeutics limited

what is your take on the lower occurrence of adverse events...

  1. 266 Posts.
    lightbulb Created with Sketch. 8
    what is your take on the lower occurrence of adverse events during clinical trials of second generation antisense drugs versus rnai. the single strand rna appears to possess the ability to use at higher doses than normal rnai drugs without as many harmful side effects. I guess well find out after the 1103 dose escillation study. but this appears to be the case.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $145.4K 1.739M

Buyers (Bids)

No. Vol. Price($)
1 69272 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 71037 1
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.